Pitanje br. 16665
 
Pitanje: 
 Lipoproteini, mjerenje razine HDL-kolesterola i HDL/ukupni kolesterol
Odgovor: 
 Poglavlja u knjigama:

  1. Zaputović, Luka. Kako možemo povećati HDL kolesterol lijekovima?. // Prevencija ateroskleroze : smanjeni HDL-kolesterol kao čimbenik rizika : zbornik radova sa Znanstvenog skupa održanog 13. travnja 2010. u Zagrebu / urednik Željko Reiner. Zagreb : Hrvatska akademija znanosti i umjetnosti, 2011.; str. 67-80. - sign.  616.1 /ZNA/ p  OP


Knjige:


  1. Štrausova medicinska biokemija / urednice Dubravka Čvorišćec i Ivana Čepelak. Zagreb : Medicinska naklada, 2009. - sign.  61(075.8) /ŠTR/

  2. Berg, Jeremy Mark. Biokemija. Zagreb : Školska knjiga, 2013. - sign.  577(075.8) /BER/ b

  3. Karlson, Peter. Biokemija : udžbenik za studente tehnološkog, prehrambeno-tehnološkog, biotehnološkog, prirodoslovno-matematičkog, medicinskog i farmaceutsko-biokemijskog fakulteta. Zagreb : Školska knjiga, 1993. - sign.  577(075.8) /KAR/ b

  4. Stryer, Lubert. Biokemija. Zagreb : Školska knjiga, 1991. - sign.  577(075.8) /STR/ b


Članci u časopisima:


  1. Horvat, Dunja. Određivanje koncentracije HDL-kolesterola: značenje hipertrigliceridemije pri izboru metode. // Biochemia Medica. - 10 (2000), 3-4; str. 137-143.

  2. Reiner, Željko. Sniženi HDL-kolesterol – važan čimbenik rizika od kardiovaskularnih bolesti. // Liječnički vjesnik. - 133 (2011), 3-4; str. 111-116.

  3. Reiner, Željko. Važnost intenzivnog snižavanja LDL kolesterola – uloga "jačih" statina. // Cardiologia Croatica. - 7 (2012), 5-6; str. 187-194.


Izvori na internetu (29.03.2021.):


  1. Calling, Susanna. The ratio of total cholesterol to high density lipoprotein cholesterol and myocardial infarction in Women’s health in the Lund area (WHILA): a 17-year follow-up cohort study. // BMC Cardiovascular Disorders. - 19 (2019). URL: https://bmccardiovascdisord.biomedcentral.com/track/pdf/10.1186/s12872-019-1228-7.pdf

  2. Hafiane, Anouar. High density lipoproteins: Measurement techniques and potential biomarkers of cardiovascular risk. // BBA clinical. - 3 (2015); str. 175-188. URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4661556/pdf/main.pdf

  3. Lemieux, Isabelle. Total Cholesterol/HDL Cholesterol Ratio vs LDL Cholesterol/HDL Cholesterol Ratio as Indices of Ischemic Heart Disease Risk in Men: The Quebec Cardiovascular Study. // Archives of Internal Medicine. - 161 (2001), 22; str. 2685–2692. URL: https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/752318

  4. Masson, W. Association between triglyceride/HDL cholesterol ratio and carotid atherosclerosis in postmenopausal middle-aged women. // Endocrinology and Nutrition. - 63 (2016); str. 327–332. URL: https://www.elsevier.es/en-revista-endocrinologia-nutricion-english-edition--412-articulo-association-between-triglyceride-hdl-cholesterol-ratio-S2173509316300654

  5. Millán, Jesús. Lipoprotein ratios: Physiological significance and clinical usefulness in cardiovascular prevention. // Vascular health and risk management. - 5 (2009); 757-765. URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2747394/

  6. Quispe, Renato. Total cholesterol/HDL-cholesterol ratio discordance with LDL-cholesterol and non-HDL-cholesterol and incidence of atherosclerotic cardiovascular disease in primary prevention: The ARIC study. // European Journal of Preventive Cardiology. - 27 (2020), 15; str. 597–1605. URL: https://academic.oup.com/eurjpc/article-pdf/27/15/1597/34339659/eurjpc1597.pdf

  7. Warnick, G. Russell. Standardization of Measurements for Cholesterol, Triglycerides, and Major Lipoproteins. // Labmedicine. - 39 (2008), 8; str. 481-490. URL: https://is.gd/MQHgxj
UDK pojmovi: 
616 Patologija. Klinička medicina, 577 Biokemija
Predmetnice: 
 Kolesterol -- Ateroskleroza